Regenerative Medicine Institute, Mexico Presents Summary of Clinical Data at the International Society of Stem Cell Research
Username or Email Address
Do you already have an account?
Forgot your password?
  • Log in or Sign up

    Welcome to InvestorStemCell
    The Future is NOW! Be a part of the Future of Medicine and join the InvestorStemCell Community! InvestorStemCell is the worlds only community dedicated to Regenerative Medicine. Get started by signing up!
    Results 1 to 3 of 3
    Like Tree5Likes
    • 2 Post By digeratidesigns
    • 2 Post By JHam
    • 1 Post By Marco Polo III

    Regenerative Medicine Institute, Mexico Presents Summary of Clinical Data at the International Society of Stem Cell Research

    1. #1
      Sagacious Member digeratidesigns's Avatar

      Regenerative Medicine Institute, Mexico Presents Summary of Clinical Data at the International Society of Stem Cell Research

      http://www.marketwatch.com/story/reg...rch-2012-04-23

      TIJUANA, Mexico, Apr 23, 2012 (GlobeNewswire via COMTEX) -- Regenerative Medicine Institute, Mexico (RMI) will be among top scientists and physicians presenting cutting edge data at the International Society of Stem Cell Research (ISSCR). The ISSCR's annual meeting has become the world's premier stem cell research event. The meeting serves as the largest forum for stem cell and regenerative medicine professionals from around the world. The ISSCR 10th Annual Meeting will be held June 13 - 16, 2012 at the Pacifico Yokohama in Yokohama, Japan.

      A summary of data on the use of adult stem cells from adipose tissue to treat heart failure and COPD will be presented by Kristin Comella, Chief Scientific Officer of Bioheart Inc. Bioheart is focused on the discovery, development, and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. RMI is currently running Phase I/II trials at the Hospital Angeles in collaboration with Bioheart and the Ageless Regenerative Institute.

      Dr. Javier Lopez, President and CEO of RMI and a member of ISSCR said that "We are proud to share our initial results with the scientific community at such a prestigious event."

      For more information on RMI, visit Stem Cell Therapy Mexico Stem Cell Therapy Overseas Stem Cell Treatment Mexico

      This news release was distributed by GlobeNewswire, GlobeNewswire - Press Release Distribution - EDGAR Filings - Video News Releases

      SOURCE: Regenerative Medicine Institute, Mexico



      CONTACT: Dr. Javier Lopez, (619) 421-0700



      (C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
      JHam and EYESEE like this.

    2. #2
      JHam
      Guest JHam's Avatar
      Thanks for posting. I am hoping to be at the ISSRC annual meeting since it is local. That is if I am permitted and it does not cost $1,000 to get in.
      michaelbrom and EYESEE like this.

    3. #3
      Marco Polo III's Avatar
      This could be the jump we need to start rolling.!!!!


      Quote Originally Posted by digeratidesigns View Post
      Regenerative Medicine Institute, Mexico Presents Summary of Clinical Data at the International Society of Stem Cell Research - MarketWatch

      TIJUANA, Mexico, Apr 23, 2012 (GlobeNewswire via COMTEX) -- Regenerative Medicine Institute, Mexico (RMI) will be among top scientists and physicians presenting cutting edge data at the International Society of Stem Cell Research (ISSCR). The ISSCR's annual meeting has become the world's premier stem cell research event. The meeting serves as the largest forum for stem cell and regenerative medicine professionals from around the world. The ISSCR 10th Annual Meeting will be held June 13 - 16, 2012 at the Pacifico Yokohama in Yokohama, Japan.

      A summary of data on the use of adult stem cells from adipose tissue to treat heart failure and COPD will be presented by Kristin Comella, Chief Scientific Officer of Bioheart Inc. Bioheart is focused on the discovery, development, and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. RMI is currently running Phase I/II trials at the Hospital Angeles in collaboration with Bioheart and the Ageless Regenerative Institute.

      Dr. Javier Lopez, President and CEO of RMI and a member of ISSCR said that "We are proud to share our initial results with the scientific community at such a prestigious event."

      For more information on RMI, visit Stem Cell Therapy Mexico Stem Cell Therapy Overseas Stem Cell Treatment Mexico

      This news release was distributed by GlobeNewswire, GlobeNewswire - Press Release Distribution - EDGAR Filings - Video News Releases

      SOURCE: Regenerative Medicine Institute, Mexico



      CONTACT: Dr. Javier Lopez, (619) 421-0700



      (C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
      EYESEE likes this.

    Tags for this Thread